#pharmacist, #pharmacologist, PhD student @UQCCR,#Antimicrobial #PK/PD, #HFIM, #popPK, #AMO
Brisbane, Queensland
Joined November 2023
- Tweets41
- Following118
- Followers32
- Likes66
Getnet M Assefa retweeted
💡 Take your clinical trial from concept to completion. Learn how to design, conduct and report a clinical trial through expert-led sessions and workshops covering every stage of the clinical trial journey.
Register today: ow.ly/lStL50Zrgqa
Getnet M Assefa retweeted
🎉 Five years of research impact. One afternoon of inspiring discussion.
Join us at the Five Years of CRE RESPOND Forum to hear leading researchers and clinicians discuss precision dosing, antimicrobial stewardship, sepsis, AMR, ECMO, fungal infections and more.
📅 13 Nov 2026
📍 Herston + Online
🎟️ Register: cre-respond.centre.uq.edu.au…
#CRERESPOND #AntimicrobialStewardship #InfectiousDiseases #AMR #PrecisionDosing
Getnet M Assefa retweeted
🌍 #REVIVE welcomes 19 new experts to its global community in 2026.
Their expertise spans infectious diseases, microbiology, epidemiology, drug discovery, clinical research, regulatory affairs and #AMR.
From ETH Zurich and UCL to Mahidol University, the University of Queensland, the University of Cape Town and NUS, they bring diverse perspectives to a shared challenge.
Because tackling antimicrobial resistance takes more than one discipline. It takes connections across research, discovery, clinical practice, policy and access.
Welcome to REVIVE! 🤝
#GARDP #GlobalHealth
Getnet M Assefa retweeted
📢 Reminder: Registrations are still open for our Dose Optimisation and Life-Support Therapies Seminar on 17 September.
Hear from Dr Marta Ulldemolins, @HaifaLyster, @paulcritpharm, with Prof @jasonroberts_pk as Chair.
📍 Frazer Institute, Herston | 💻 Zoom
Register today: bit.ly/4xrKiRy
#CRERESPOND #CriticalCare #ECMO #AntimicrobialStewardship #PrecisionDosing
Getnet M Assefa retweeted
🔥 Just published 🔥 @PharmacoJournal
Focused Update to International Consensus Recommendations for the Use of Prolonged-Infusion Beta-Lactam Antibiotics Among Severely Ill Adult Patients
Led by Lisa Hong 🌟
Endorsed by:
@ACCP @BSACandJAC @IDSAInfo @ESCMID @SCCM @CF_Foundation @SIDPharm
#IDXposts
EnJoy
accpjournals.onlinelibrary.w…
🤖 Made with AI
Getnet M Assefa retweeted
🔥FDA has approved Zaynich (cefepime and zidebactam) for adults with complicated urinary tract infections (cUTIs) caused by designated susceptible microorganisms.🔥 #idxposts
@BradSpellberg @IDstewardship accessdata.fda.gov/drugsatfd…
Getnet M Assefa retweeted
On this week: CRE RESPOND’s Precision Dosing Seminar!
Chaired by Professor Jason Roberts (@jasonroberts_pk), with sessions on beta‑lactam dosing, S. aureus bacteraemia optimisation, and antibacterial dosing in ECMO.
Featuring A/Prof Erin Barreto (@erin_barreto), Rekha Mangalore, Leon Smareglia & Hafiz Abdul‑Aziz.
Registration is free — we’d love for you to join us: bit.ly/4wFKexM
#CRERESPOND #PrecisionDosing #AntimicrobialStewardship #InfectiousDiseases #MedEd
Getnet M Assefa retweeted
📣 A quick reminder that our 3‑day Fundamentals of Population Pharmacokinetics workshop is coming up! Whether you’re stepping into PK for the first time or refreshing your understanding, you’ll get guided, practical experience with real datasets and model‑building workflows.
📅 15–17 July 2026
📍 UQ Brisbane City
💲AUD 650
We’ll cover key PK principles, PopPK basics, dataset construction, model development, validation, and Monte Carlo simulations — all in a supportive, beginner‑friendly environment.
🎟️ Registration and details: bit.ly/4rKjd9L
Getnet M Assefa retweeted
The AMR Action Subcommittee and Study Group for Artificial intelligence and Digitalisation (ESGAID) recently published a perspective on the implications of using AI in the fight against #AMR. Check it out: ow.ly/Bbwm50YeZTF
Getnet M Assefa retweeted
Super interesting!
🆕💫Keeping the horse *with the cart: are we underdosing tazobactam even when using continuous-infusion ceftolozane/tazobactam for effectively preventing resistance development by ESBL-producing Enterobacterales #IDXposts
journals.asm.org/doi/10.1128…
Getnet M Assefa retweeted
🙌We are proud to introduce CRE RESPOND's final seminar of the year as part of the Education Program 2025!🙌
We're thrilled to announce that the UTI Guidelines: Clinical practice guidelines on prevention and management of Urinary Tract Infections (UTIs) seminar will take place on:
📅Thursday 20th November, 12pm-1pm AEST
At the:
📍Auditorium of the UQ Centre for Clinical Research
Our speakers include guideline authors and committee members who will present on the newly published clinical practice guidelines for UTI's📖
Register here: bit.ly/48ZZgoE
#CRERESPOND #UQCCR #UTI #Guidelines #Infections #Prevention #Management #UrinaryTract
Getnet M Assefa retweeted
Super interesting!
🆕💫Comparative in vitro activity of ceftazidime-avibactam plus aztreonam and the fixed combination aztreonam/avibactam against multidrug-resistant Pseudomonas aeruginosa #idxposts
The punch effect! academic.oup.com/jac/article…
Getnet M Assefa retweeted
New RCT from @UQMedicine Cefiderocol versus standard therapy for healthcare-associated Gram-negative BSI @UQ_GAMECHANGER @UQ_News >500 patients in 6 countries with high rates of MDR; 25% carb-R; Non-inferior but not superior for 14d mortality @TheLancetInfDis @davidantibiotic
Getnet M Assefa retweeted
🤩The third instalment of the CRE RESPOND quarterly newsletter will be sent out tomorrow!🤩
📣 Our newsletter lets you stay informed on our talented and dedicated team of researchers and their current projects and publications, as well as our visitors who come from all over the world to work with us.
If you want to learn all about the team and the amazing work they do, our newsletter is the best place to find all that information in one go!
Subscribe here: bit.ly/4enYORH
In advance of its release tomorrow, here's a little sneak peak of what you can expect... 🤫
Getnet M Assefa retweeted
💥 BIG problems need BIG solutions
Drug resistance is putting lives at risk worldwide.
That’s why we’re launching #ThisIsBig—a bold campaign calling for greater investment and collaboration to develop new antibiotics and expand access to treatment 🚀
📢 Share the video. Join the movement.
🔗 gardp.org/this-is-big
Getnet M Assefa retweeted
SO excited to officially announce the 2024 Pharmacy to Dose Award winners! 🎉 🍾
Research article of the year: Jason Roberts @jasonroberts_pk
Non-research article of the year : Mojdeh Heavner @HeavnerPharmD
Preceptor of the Year: Grace Benanti
Mentor of the Year: Brian Gilbert @GilbertPharmD
Conference Speaker of the Year: Gretchen Sacha @gretchensacha
Unsung Hero award: Caitlin Brown @CBthePHARMD
Tag Team Tandem Award: Kat Spezzano and Christian Kressin @KatSpazPharmD @CKressinPharmD
People’s Choice Award: Andy Webb @AJWPharm
Black Cloud award: Haley Peters
MVP: Anthony Hawkins @iamahawkins
Living Legend award: Nicole Acquisto
Thank you so much everyone for voting!! Full awards episode coming very soon 👀 👏🏻
Getnet M Assefa retweeted
🌟NEW in IJAA🌟
Authors find #OPAT is a safe and effective alternative to inpatient IV #antimicrobial treatment in this systematic review & meta-analysis which includes >1,300 patients.
Read the open access article⬇️
tinyurl.com/43jmdc3c
Getnet M Assefa retweeted
🆕️🔥State of the art review article #JAC 🌟s @jasonroberts_pk @b_fekade @MGilchrist123
Current Practices and challenges of outpatient parenteral antimicrobial therapy #OPAT #IDXposts #bookmark
Great tables🎯
academic.oup.com/jac/article…
